drugset / Trial / NCT02868918

Evaluation of Biodentine Versus Glass Ionomer Cement in Treatment of Very Deep Carious Lesions

NCT02868918

Phase 3 Completed 120 enrolled Cairo University
RandomizedParallel-groupSingle-blindHealth-services research

Summary

The aim of this study is to compare the effect of new bioactive dentine substitute (Biodentine) versus glass ionomer cement in very deep carious lesions clinically and radiographically using digital radiography in the terms of postoperative pain and biocompatibility to the pulp.

Timeline

Start
2018-02-01
Primary completion
2019-01-01
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Biodentine Other / unclassified
Comparator Fuji IX Unknown

Indications